A brain-computer interface capable of decoding Mandarin Chinese from brain signals may help people with paralysis or ALS to ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

These are scenes that no longer belong to science fiction but of real-world applications of brain-computer interface (BCI) technology in China. With a multimodal BCI headband, signals from the brain ...

InBrain Neuroelectronics announced today that it entered into a strategic collaboration with Microsoft to explore AI in ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.